Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Pharyngeal cancer, Secondary cancers
Closed
Phase 2
This trial is comparing lenvatinib and pembrolizumab with for cancer of the head and neck. It is also looking at lenvatinib on its own.
The trial is for people whose cancer has come back or spread after previous treatment.
It includes people who have one of the following types of head and neck cancer:
cancer of the area that surrounds the voice box ()
cancer of the voice box (laryngeal cancer)
Recruitment start: 18 December 2020
Recruitment end: 5 September 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Petra Jankowska
Merck Sharp & Dohme Ltd
Last reviewed: 15 Sept 2024
CRUK internal database number: 17521
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
